<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Stages of mitral stenosis</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Stages of mitral stenosis</h1>
<div class="graphic"><div class="figure"><div class="ttl">Stages of mitral stenosis</div><div class="cntnt"><table cellspacing="0"><colgroup width="10%"></colgroup><colgroup span="4" width="20%"></colgroup><colgroup width="10%"></colgroup> <tbody> <tr class="divider_bottom"> <td class="subtitle1">Stage</td> <td class="subtitle1">Definition</td> <td class="subtitle1">Valve anatomy</td> <td class="subtitle1">Valve hemodynamics</td> <td class="subtitle1">Hemodynamic consequences</td> <td class="subtitle1">Symptoms</td> </tr> <tr class="divider_bottom"> <td class="centered">A</td> <td>At risk of MS</td> <td> <ul> <li>Mild valve doming during diastole</li> </ul> </td> <td>Normal transmitral flow velocity</td> <td>None</td> <td>None</td> </tr> <tr class="divider_bottom"> <td class="centered">B</td> <td>Progressive MS</td> <td> <ul> <li>Rheumatic valve changes with commissural fusion and diastolic doming of the mitral valve leaflets</li> <li>Planimetered MVA &gt;1.5 <span class="nowrap_whitespace">cm<sup>2</sup></span></li> </ul> </td> <td> <ul> <li>Increased transmitral flow velocities</li> <li>MVA &gt;1.5 <span class="nowrap_whitespace">cm<sup>2</sup></span></li> <li>Diastolic pressure half-time &lt;150 ms</li> </ul> </td> <td> <ul> <li>Mild-to-moderate LA enlargement</li> <li>Normal pulmonary pressure at rest</li> </ul> </td> <td>None</td> </tr> <tr class="divider_bottom"> <td class="centered">C</td> <td>Asymptomatic, severe MS</td> <td> <ul> <li>Rheumatic valve changes with commissural fusion and diastolic doming of the mitral valve leaflets</li> <li>Planimetered MVA ≤1.5 <span class="nowrap_whitespace">cm<sup>2</sup></span></li> <li>(MVA ≤1 <span class="nowrap_whitespace">cm<sup>2</sup></span> with very severe MS)</li> </ul> </td> <td> <ul> <li>MVA ≤1.5 <span class="nowrap_whitespace">cm<sup>2</sup></span></li> <li>(MVA ≤1 <span class="nowrap_whitespace">cm<sup>2</sup></span> with very severe MS)</li> <li>Diastolic pressure half-time ≥150 ms</li> <li>(Diastolic pressure half-time ≥220 ms with very severe MS)</li> </ul> </td> <td> <ul> <li>Severe LA enlargement</li> <li>Elevated PASP &gt;30 mmHg</li> </ul> </td> <td>None</td> </tr> <tr class="divider_bottom"> <td class="centered">D</td> <td>Symptomatic severe MS</td> <td> <ul> <li>Rheumatic valve changes with commissural fusion and diastolic doming of the mitral valve leaflets</li> <li>Planimetered MVA ≤1.5 <span class="nowrap_whitespace">cm<sup>2</sup></span></li> </ul> </td> <td> <ul> <li>MVA ≤1.5 <span class="nowrap_whitespace">cm<sup>2</sup></span></li> <li>(MVA ≤1 <span class="nowrap_whitespace">cm<sup>2</sup></span> with very severe MS)</li> <li>Diastolic pressure half-time ≥150 ms</li> <li>(Diastolic pressure half-time ≥220 ms with very severe MS)</li> </ul> </td> <td> <ul> <li>Severe LA enlargement</li> <li>Elevated PASP &gt;30 mmHg</li> </ul> </td> <td> <ul> <li>Decreased exercise tolerance</li> <li>Exertional dyspnea</li> </ul> </td> </tr> </tbody></table></div><div class="graphic_lgnd">The transmitral mean pressure gradient should be obtained to further determine the hemodynamic effect of the MS and is usually &gt;5 to 10 mmHg in severe MS; however, due to the variability of the mean pressure gradient with heart rate and forward flow, it has not been included in the criteria for severity. This table has been reprinted, nearly unchanged, in the 2020 ACC/AHA guideline for the management of patients with valvular heart disease; however, the 2020 guideline no longer includes criteria for "very severe MS" in the valve anatomy and valve hemodynamics columns.</div><div class="graphic_footnotes">LA: left atrial; LV: left ventricular; MS: mitral stenosis; MVA: mitral valve area; PASP: pulmonary artery systolic pressure; ACC: American College of Cardiology; AHA: American Heart Association.</div><div class="graphic_reference">Reproduced from: Nishimura RA, Otto CM, Bonow RO, et al. 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2014; 63:e57. Table used with the permission of Elsevier Inc. All rights reserved.</div><div id="graphicVersion">Graphic 97546 Version 3.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
